Goldman Sachs’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.7M Buy
1,239,207
+669,845
+118% +$22M ﹤0.01% 1894
2025
Q4
$21.3M Sell
569,362
-77,291
-12% -$2.54M ﹤0.01% 2313
2025
Q3
$17.8M Sell
646,653
-74,028
-10% -$2.55M ﹤0.01% 2372
2025
Q2
$22.8M Buy
720,681
+375,915
+109% +$12.1M ﹤0.01% 2008
2025
Q1
$11.4M Sell
344,766
-150,282
-30% -$5.39M ﹤0.01% 2563
2024
Q4
$17M Buy
495,048
+187,035
+61% +$6.43M ﹤0.01% 2294
2024
Q3
$12.3M Sell
308,013
-147,351
-32% -$5.18M ﹤0.01% 2510
2024
Q2
$13.7M Buy
455,364
+244,410
+116% +$7.35M ﹤0.01% 2202
2024
Q1
$7.08M Sell
210,954
-60,146
-22% -$1.93M ﹤0.01% 2790
2023
Q4
$8.76M Buy
271,100
+69,142
+34% +$1.93M ﹤0.01% 2656
2023
Q3
$6.62M Sell
201,958
-115,045
-36% -$3.99M ﹤0.01% 2746
2023
Q2
$11.2M Sell
317,003
-11,331
-3% -$391K ﹤0.01% 2342
2023
Q1
$10.7M Buy
328,334
+219,310
+201% +$9.99M ﹤0.01% 2356
2022
Q4
$6.01M Sell
109,024
-56,587
-34% -$3.11M ﹤0.01% 3008
2022
Q3
$7.33M Buy
165,611
+97,334
+143% +$4.75M ﹤0.01% 2799
2022
Q2
$3.33M Buy
68,277
+4,618
+7% +$208K ﹤0.01% 3572
2022
Q1
$3.1M Buy
63,659
+16,753
+36% +$683K ﹤0.01% 3828
2021
Q4
$2M Sell
46,906
-7,610
-14% -$303K ﹤0.01% 4249
2021
Q3
$2.09M Buy
54,516
+25,955
+91% +$836K ﹤0.01% 4164
2021
Q2
$806K Buy
28,561
+14,741
+107% +$442K ﹤0.01% 4917
2021
Q1
$457K Buy
13,820
+4,935
+56% +$173K ﹤0.01% 5192
2020
Q4
$321K Sell
8,885
-29,178
-77% -$1.18M ﹤0.01% 4853
2020
Q3
$1.29M Buy
+38,063
New +$1.39M ﹤0.01% 3897

Other funds holding HRMY